who should not take glp 1 medications Chart: in 8 Americans Now Use GLP-1 Drugs for Weight Loss GLP-1 Medications Infographic | Medidex

widely used off-label for weight loss Mounjaro (tirzepatide) FDA-approved for Type 2 diabetes Saxenda (liraglutide) FDA-approved for weight management These shots can cost $900$1,300 per month without insurance

Nutrition and behavior change remain foundational, whether someone chooses to use a GLP-1 or not. In the first nine months of 2025, major pharmaceutical companies spent more than $700 million advertising GLP-1 medications2, with Eli Lilly spending approximately $34 million on television spots in January 2026.3 Yet the 2026 Virta Vitals report suggests that growing awareness of GLP-1s has not necessarily translated into greater willingness to use them

There were no significant differences in the incidence of total or hip fracture between the calorie restriction and control groups

The surge in popularity of Ozempic sheds light on the impact of socioeconomic factors in accessing the drug

GLP-1 Trends GLP-1s are a class of medications originally approved for type 2 diabetes management that have seen dramatic growth in prescribing following expanded approvals for chronic weight management